Anti-HIV agents. AMD-3100--chemokine blocker under study.
D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D001596:Benzylamines; D001921:Brain / Q000378:metabolism; D018925:Chemokines / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000080027:Cyclams; D006571:Heterocyclic Compounds / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology*; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects
D019380:Anti-HIV Agents; D001596:Benzylamines; D018925:Chemokines; D000080027:Cyclams; D006571:Heterocyclic Compounds; C088327:plerixafor